KB-128

N/A

Report date: 2025/05/15 15:19:52
NME

Base Information

Drug NameKB-128
Drug Alias NameKB-128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2b (5-HT2b) receptor antagonistsSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2b (5-HT2b) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsSchizophreniaSubstance-Related DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKüleon LLC
China Registration ClassN/A

Develop Information

Active CompaniesKüleon LLC
Inactive CompaniesN/A
Active IndicationsSchizophreniaSubstance-Related DisordersObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A